Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
British Journal of Haematology
|
July 3, 2023
Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms
Anne S Reiner, Benjamin H Durham, Mariko Yabe, et al.
The American Journal of Surgical Pathology
|
March 3, 2020
Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma
Ying Liu, Fatima Jelloul, Yanming Zhang, et al.
JCO Precision Oncology
|
November 9, 2020
Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of <i>SMARCB1</i>
Michael D Kinnaman, Darcy Hamill, Mariko Yabe, et al.
American Journal of Hematology
|
September 13, 2008
Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: does body weight matter?
Yoshinobu Kanda, Shinichiro Okamoto, Tetsuzo Tauchi, et al.
Neuro-Oncology
|
January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series
Ankush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.
British Journal of Haematology
|
July 1, 2015
TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis
Sanam Loghavi, Alyaa Al-Ibraheemi, Zhuang Zuo, et al.
Haematologica
|
April 18, 2020
Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition
JinJuan Yao, Lianrong Xu, Umut Aypar, et al.
Leukemia
|
November 8, 2024
The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms
Mali Salmon-Divon, Refael Meyuchas, Ofer Shpilberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2016
Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma
Juliana E Hidalgo Lopez, Mariko Yabe, Adrian A Carballo-Zarate, et al.
Blood Advances
|
October 24, 2023
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
Benjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
British Journal of Haematology
|
July 3, 2023
Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms
Anne S Reiner, Benjamin H Durham, Mariko Yabe, et al.
The American Journal of Surgical Pathology
|
March 3, 2020
Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma
Ying Liu, Fatima Jelloul, Yanming Zhang, et al.
JCO Precision Oncology
|
November 9, 2020
Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of <i>SMARCB1</i>
Michael D Kinnaman, Darcy Hamill, Mariko Yabe, et al.
American Journal of Hematology
|
September 13, 2008
Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: does body weight matter?
Yoshinobu Kanda, Shinichiro Okamoto, Tetsuzo Tauchi, et al.
Neuro-Oncology
|
January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series
Ankush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.
British Journal of Haematology
|
July 1, 2015
TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis
Sanam Loghavi, Alyaa Al-Ibraheemi, Zhuang Zuo, et al.
Haematologica
|
April 18, 2020
Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition
JinJuan Yao, Lianrong Xu, Umut Aypar, et al.
Leukemia
|
November 8, 2024
The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms
Mali Salmon-Divon, Refael Meyuchas, Ofer Shpilberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2016
Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma
Juliana E Hidalgo Lopez, Mariko Yabe, Adrian A Carballo-Zarate, et al.
Blood Advances
|
October 24, 2023
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
Benjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, et al.
Page
of 6